Dysregulation of protein degradation pathways may mediate the liver injury and phospholipidosis associated with a cationic amphiphilic antibiotic drug.
about
A Synopsis of the "Influence of Epigenetics, Genetics, and Immunology" Session Part A at the 35th Annual Society of Toxicologic Pathology Symposium.New Rodent Population Models May Inform Human Health Risk Assessment and Identification of Genetic Susceptibility to Environmental Exposures.Editor's Highlight: Candidate Risk Factors and Mechanisms for Tolvaptan-Induced Liver Injury Are Identified Using a Collaborative Cross Approach.
P2860
Dysregulation of protein degradation pathways may mediate the liver injury and phospholipidosis associated with a cationic amphiphilic antibiotic drug.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Dysregulation of protein degra ...... c amphiphilic antibiotic drug.
@en
Dysregulation of protein degra ...... c amphiphilic antibiotic drug.
@nl
type
label
Dysregulation of protein degra ...... c amphiphilic antibiotic drug.
@en
Dysregulation of protein degra ...... c amphiphilic antibiotic drug.
@nl
prefLabel
Dysregulation of protein degra ...... c amphiphilic antibiotic drug.
@en
Dysregulation of protein degra ...... c amphiphilic antibiotic drug.
@nl
P2093
P1476
Dysregulation of protein degra ...... c amphiphilic antibiotic drug.
@en
P2093
C Lisa Kurtz
Karissa Adkins
Stephen P Schmidt
P356
10.1016/J.TAAP.2014.06.013
P577
2014-06-23T00:00:00Z